Treatment of Microscopic Colitis
NCT00184171 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105
Last updated 2015-01-21
Summary
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
Conditions
Interventions
- DRUG
-
Budesonide
Budesonide 9 mg
- DRUG
-
Bismuth
Bismuth mixture
- DRUG
-
Fiber
Fiber for control
Sponsors & Collaborators
- collaborator INDUSTRY
-
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Per G Farup, PhD · Norwegian University of Science and Technology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Primary Completion
- 2010-09-30
- Completion
- 2014-10-31
Countries
- Norway
Study Locations
More Related Trials
-
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
NCT00450086 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Treatment of Collagenous Colitis With Budesonide
NCT00139165 ·Status: UNKNOWN ·Phase: PHASE3
-
Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
NCT05341401 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
NCT04607837 ·Status: COMPLETED ·Phase: PHASE2
-
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
NCT01209208 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
NCT04314375 ·Status: RECRUITING ·Phase: PHASE4
-
The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis
NCT01349673 ·Status: TERMINATED ·Phase: PHASE3
-
SOIBD Collagenous Colitis Maintenance Study
NCT01278082 ·Status: COMPLETED ·Phase: PHASE3
-
Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
NCT00747110 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Nutritional Therapies for the Treatment of Ulcerative Colitis
NCT03444311 ·Status: TERMINATED ·Phase: NA
-
Budesonide 9 mg Capsules in Active UC
NCT02550418 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of UC With Novel Therapeutics
NCT06420375 ·Status: RECRUITING ·Phase: PHASE2
-
(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
NCT00801723 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis
NCT03412682 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized B-fructan Diet in Inflammatory Bowel Disease Patients
NCT05615779 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04987307 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
NCT00805285 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
NCT01008410 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
NCT01008423 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
NCT01805791 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
NCT05976802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
NCT01882764 ·Status: TERMINATED ·Phase: PHASE3
-
Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment
NCT06867042 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
NCT00300118 ·Status: COMPLETED ·Phase: PHASE3
-
9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
NCT01086553 ·Status: COMPLETED ·Phase: PHASE3